Impact on California

Government agencies play a critical role in funding scientific research and ensuring that discoveries are quickly and safely made available to the public. Legislators and elected officials have the important task of making sure that the engine of life sciences runs smoothly. From university labs to FDA approval, and access to seed funding to workforce preparedness, government creates the climate in which innovation and economic growth either flourishes or fails. We have compiled the statistics below to help you evaluate the impact of California's life sciences industry.

Top 5 Bay Area Growth Areas

1. Cancer
2. Dermatology
3. HIV/AIDS
4. Diabetes
5. Cardiovascular Diseases

Treatments in California's R&D Pipeline

There are 233 treatments in Stage III clinical trials, moving towards approval and manufacturing. This is arguably the most critical point in the R&D pipeline for sustained and continued support.

Unfortunately, California has lost more life science manufacturing jobs than any other state. Most states have lost manufacturing jobs since 200. According to a 2009 report by the Milken Institute on California manufacturing, California has lost 30% of its industrial base since December 2000, more than any other state. Comparatively, Texas manufacturing gained 24% if its Gross State Product and Oregon gained 66%.

2009 Increase in Capital Investment

California’s biotechnology and medical device industries, as a percentage of the total venture capital investment in all industries, increased from 2008 to 2009.

2009 NIH Grants by Type of Organization

California universities received the majority of NIH funding in 2009. Technology transfer programs, which connect researcher with industry, are a critical component of California’s innovation economy.